Significant Ownership of Fortress Biotech, Inc.

Signature - Title: /s/ Lindsay A. Rosenwald - Lindsay A. Rosenwald, M.D. / Chairman, President and Chief Executive Officer
Location: Bay Harbor Islands, FL
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Fortress Biotech, Inc..

Notify me when Fortress Biotech, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Fortress Biotech, Inc.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ATXI	Avenue Therapeutics, Inc.	Common Stock, $0.0001 Par Value	13%	$290,370	+$73,398	439,955	+34%	Fortress Biotech, Inc.	02 Jan 2026
MBIO	Mustang Bio, Inc.	Common Stock, $0.0001 Par Value	12%	$1,708,057		6,569,450		Fortress Biotech, Inc.	31 Dec 2024
MBIO	Mustang Bio, Inc.	Common Stock, $0.0001 Par Value	8%	$698,416	+$361,900	537,243	+108%	Fortress Biotech, Inc.	02 Jan 2026
CKPT	Checkpoint Therapeutics, Inc.	Common Stock, $0.0001 Par Value	0%	$0	-$28,796,556	0	-100%	Fortress Biotech, Inc.	30 May 2025

Schedules 13D/G Reported by Fortress Biotech, Inc.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.